SOURCE: ProTrials, Inc.

ProTrials, Inc.

April 14, 2014 08:00 ET

ProTrials Completes Significant Phase III Clinical Trial for New Ophthalmic Disease Treatment

Successful Multi-Center, 700 Patient Study Investigates the Effectiveness of a Novel Treatment for Dry Eye Disease

SUNNYVALE, CA--(Marketwired - Apr 14, 2014) - ProTrials Research™, Inc., a leader in the clinical research organization (CRO) industry, today announced the completion of a large Phase III clinical study examining the safety and effectiveness of a new treatment for dry eye disease, a chronic condition affecting approximately 25 million people in the U.S. 

This milestone adds to ProTrials' successful track record in supporting ophthalmology studies investigating new treatments for a broad range of eye conditions, from age-related macular degeneration (AMD) to cataract surgery pain. In the last three years, ProTrials has conducted four Phase III dry eye studies and multiple Phase III trials across a broad range of therapeutic areas involving over 100 sites and 1000 patients. Prior to the completion of this trial, the company successfully managed and monitored parallel Phase III AMD treatment studies that resulted in a successful Biologics License Application (BLA) submission.

More than half of the company's staff has significant ophthalmology experience, and almost 90 percent have Phase III clinical trial experience.

"ProTrials offers experience in many therapeutic areas, but our ability to handle the intricacies required in ophthalmology studies is key to our repeated success in this type of research," said Inger Arum, president of ProTrials. "Sponsors choose ProTrials as a partner because of our excellent track record and the expertise of our senior-level team."

About ProTrials Research, Inc.
Founded in 1996, ProTrials Research, Inc. is a contract research organization (CRO) with regional clinical research associates and project managers based throughout North America, Canada, and Europe. The company works with clients in the pharmaceutical, biotechnology and medical device industries, providing high quality site monitoring, project management and associated clinical operations services. ProTrials is headquartered in Sunnyvale, California. For more information, visit or call (650) 864-9195.

Contact Information

  • Contact:
    Wendy Powers
    ProTrials, Inc.
    Email Contact